Gilead’s antiviral drug, Remdesivir proves hopeful in Phase 3 trial
"Study Demonstrates Similar Efficacy with 5- and 10-Day Dosing Durations of Remdesivir" Source: Gilead's News Gilead Sciences, Inc. (Nasdaq: GILD)...
"Study Demonstrates Similar Efficacy with 5- and 10-Day Dosing Durations of Remdesivir" Source: Gilead's News Gilead Sciences, Inc. (Nasdaq: GILD)...
"The diagnostic platform CARMEN combines microfluidics with the CRISPR-based detection technology SHERLOCK, and could one day be used for public...
"This study is focusing on understanding what SARS-CoV-2 does in the body, why some people are more susceptible, and how...
"Immunotherapy utilising own immune cells might also be useful in treating other difficult diseases, such as HIV, HBV, beside cancers"...
"Virtually all of the ways to fight COVID-19 hinge on finding antibodies. These little molecules can latch onto viruses and...
"Epic's machine learning model scans health records and alerts doctors automatically before patients need an ICU admission or other care...
"Supplements containing vitamins C and D and other micronutrients are a safe, effective and low-cost means of helping your immune...
"The system requires only 20 μl of swab or sputum samples, making it easy and convenient to use." Source: CHINESE...
"OU Medicine, University of Oklahoma Health Sciences Center and Oklahoma Medical Research Foundation file for FDA Emergency Use Authorization for...
"People relying on mainstream TV and print news better informed" Source: ANNENBERG PUBLIC POLICY CENTER OF THE UNIVERSITY OF PENNSYLVANIA...
"A step-by-step protocol with enough detail for other researchers to replicate in their laboratories." Source: WILEY Several tests have been...
"Survey of Michigan nursing homes at start of coronavirus suggests great improvement since just before the H1N1 pandemic." Source: MICHIGAN...